| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.0055 | 1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |